PETS vs RDGT
Petmed Express Inc. and Ridgetech Inc., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | PETS | RDGT |
|---|---|---|
| Revenue | $179.0M | $132.2M |
| Net income | $-57.3M | $-1.3M |
| Gross margin | 28.1% | 3.6% |
| Net margin | −32.0% | −0.9% |
| Return on equity | −100.4% | −3.6% |
| Diluted EPS | −$2.74 | −$17.21 |
| Dividend / share | $0.00 | · |
| Payout ratio | −0.0% | · |
| Free cash flow | $-33.0M | $-1.4M |
| Equity | $28.9M | · |
| Net debt / equity | · | · |
| Current ratio | 0.84× | 2.31× |
| Revenue CAGR 5y | −10.0% | −0.1% |
| Profit CAGR 5y | · | · |
PETS bills 1.4× the revenue of RDGT, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | PETS | RDGT |
|---|---|---|
| FY2025 | $179.0M | $132.2M |
| FY2024 | $227.0M | $120.0M |
| FY2023 | $274.1M | $124.0M |
| FY2022 | $247.6M | $120.2M |
| FY2021 | $272.3M | $164.4M |
| FY2020 | $303.6M | $133.1M |
| FY2019 | $284.1M | $117.3M |
Bottom line
| Fiscal year | PETS | RDGT |
|---|---|---|
| FY2025 | $-57.3M | $-1.3M |
| FY2024 | $-6.3M | $10.2M |
| FY2023 | $-7.5M | $-4.2M |
| FY2022 | $5.1M | $-21.1M |
| FY2021 | $18.7M | $-3.2M |
| FY2020 | $23.9M | $-8.1M |
| FY2019 | $25.9M | $-5.8M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$46,857,266 | PETS |
| FY2024 | +$107,000,362 | PETS |
| FY2023 | +$150,100,947 | PETS |
| FY2022 | +$127,369,807 | PETS |
| FY2021 | +$107,889,445 | PETS |
| FY2020 | +$170,448,367 | PETS |
| FY2019 | +$166,797,311 | PETS |
PETS has reported the higher revenue in every one of these 7 fiscal years. The gap has narrowed since the earliest year compared.
7 of 17 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −31.1 pp | RDGT |
| FY2024 | −11.3 pp | RDGT |
| FY2023 | +0.7 pp | PETS |
| FY2022 | +19.7 pp | PETS |
| FY2021 | +8.8 pp | PETS |
| FY2020 | +14.2 pp | PETS |
| FY2019 | +14.6 pp | PETS |
The higher net margin has changed hands between PETS and RDGT over this period.
7 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
PETS's net margin has been more volatile than RDGT's over the 7 comparable fiscal years — 13.2 percentage points of standard deviation against 7.2.
7 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between PETS and RDGT over these 7 fiscal years — PETS led in 5 and RDGT in 2.
7 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
RDGT's return on equity has been more volatile than PETS's over the 7 comparable fiscal years — 40.3 percentage points of standard deviation against 39.3.
7 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between PETS and RDGT over these 7 fiscal years — PETS led in 5 and RDGT in 2.
7 of 17 comparable fiscal years — a year missing data on either side is not counted.